NIPT
Non-Invasive Prenatal Testing
Non-Invasive Prenatal Testing (NIPT) is an advanced prenatal screening test available from 10 weeks of pregnancy. Using a simple blood sample from the mother, the test analyses fragments of your baby’s DNA circulating in the maternal bloodstream to assess the likelihood of certain chromosomal conditions, including Down Syndrome (Trisomy 21), Edwards Syndrome (Trisomy 18), and Patau Syndrome (Trisomy 13).
NIPT is a safe, highly accurate, and non-invasive screening option with no risk to mum or baby. It can provide early reassurance and valuable information to help support informed decisions throughout your pregnancy journey.
NIPT 1
Available from 10 weeks
✔ T21, T18, T13
Down, Edwards & Patau syndromes
✔ Results in 5 working days
✔ Includes scan on the day
£350
NIPT 2
Available from 10 weeks
✔ T21, T18, T13
Down, Edwards & Patau syndromes
✔ Sex chromosome anomalies
✔ 6 Microdeletions
Gender Determination (optional)
✔ Results in 5 working days
✔ Includes scan on the day
£375
NIPT 3
Available from 10 weeks
✔ T21, T18, T13
Down, Edwards & Patau syndromes
✔ Sex chromosome anomalies
✔ Microdeletions
✔ 92 microdeletions
Gender Determination (optional)
✔ Results in 5 working days
✔ Includes scan on the day
£425
Frequently Asked Questions about NIPT
-
Individuals choose to undergo NIPT for various personal reasons. Some may have limited knowledge of their biological family or a family history of genetic conditions. Others may pursue testing due to recurrent miscarriages or general pregnancy-related anxiety. For many, NIPT is sought primarily for reassurance.
-
Humans have 23 pairs of chromosomes, totaling 46 chromosomes. One copy of each chromosome is inherited from the mother (egg) and the other from the father (sperm).
The first 22 pairs are called autosomes and are the same in both males and females.
The 23rd pair consists of the sex chromosomes. Females have two X chromosomes, while males have one X and one Y chromosome.
An abnormality in an embryo’s chromosomal makeup can result in a specific syndrome or may lead to miscarriage. Sometimes, embryos have an abnormal number of chromosomes—a condition known as aneuploidy.
Aneuploidy is a significant factor in miscarriage, in vitro fertilization (IVF) failure, and various health conditions, including Down syndrome.
-
The accuracy of NIPT depends on the specific syndrome being screened for. While the test is highly reliable, there remains a very small chance it may not detect an affected pregnancy. Additionally, there is approximately a 0.3% chance of a false positive result. In such cases, we always recommend follow-up diagnostic testing.
NIPT is more accurate than the NHS first-trimester combined test or the second-trimester quadruple test for assessing the risk of genetic conditions. However, it is important to understand that NIPT is a screening tool, not a diagnostic test. Diagnostic procedures such as amniocentesis or chorionic villus sampling (CVS) provide definitive results but carry a risk of miscarriage. Therefore, NIPT is recommended as a safer initial step. Any concerns during pregnancy should be discussed with your healthcare provider.
-
Each cell in the human (except reproductive cells) body contains 46 chromosomes (we get 23 from our mother and 23 from father). Having too much or too few chromosomes means that our body has too many or too few genes or ‘genetic instructions’. This results in abnormalities such as trisomies (Down, Edwards, and Patau syndrome) or abnormalities in the sex chromosomes (including Klinefelter, Turner, Jacobs, and Triple X syndrome). However, the number of chromosomes may be typical, but there might be missing or duplicated fraction of the chromosome. This is called deletion or duplication. Because such changes are tiny, they are often difficult to detect before birth. Our NIPT test technology, however, scans all chromosomes and can detect 92 deletion and duplication syndromes in our NIPT 3.
-
A negative result does not rule out the possibility of other chromosomal abnormalities, genetic conditions, or birth defects in the pregnancy. There is also a small chance that the test results may reflect the chromosomal makeup of the mother or placenta rather than the baby—a situation known as “placental mosaicism.” Additionally, the presence of a tumour, which can have abnormal chromosome numbers, may affect the results.
-
A negative result indicates a decreased likelihood of the tested condition. In most cases, the condition is indeed not present (true negative), though rarely, it may still be present (false negative).
A positive result indicates an increased likelihood of the condition. In most cases, the condition is truly present (true positive), but in some instances, it may not be (false positive).
As NIPT is a screening test, results should be interpreted in the context of the overall pregnancy. Positive results should always be confirmed through diagnostic testing before making any pregnancy management decisions.
-
Please be aware that a small number of samples may fail the NIPT process if there is insufficient fetal DNA in the mother’s blood for analysis. Testing during the second, third, and fourth trimesters benefits from the lowest failure rates of any NIPT currently available, at approximately 0.1%.
Get In Touch For More Info
Our friendly reception team will be more than happy to answer any questions you may have.